221 related articles for article (PubMed ID: 33125407)
1. Effects of experimental cervical spinal cord injury on peripheral adaptive immunity.
Ulndreaj A; Tzekou A; Siddiqui AM; Fehlings MG
PLoS One; 2020; 15(10):e0241285. PubMed ID: 33125407
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Antibody Response after Cervical Spinal Cord Injury.
Ulndreaj A; Tzekou A; Mothe AJ; Siddiqui AM; Dragas R; Tator CH; Torlakovic EE; Fehlings MG
J Neurotrauma; 2017 Mar; 34(6):1209-1226. PubMed ID: 27775474
[TBL] [Abstract][Full Text] [Related]
3. IgM Immunoglobulin Influences Recovery after Cervical Spinal Cord Injury by Modulating the IgG Autoantibody Response.
Ulndreaj A; Vidal PM; Forgione N; Hong J; Fehlings MG
eNeuro; 2021; 8(5):. PubMed ID: 34413082
[TBL] [Abstract][Full Text] [Related]
4. The effects of human immunoglobulin G on enhancing tissue protection and neurobehavioral recovery after traumatic cervical spinal cord injury are mediated through the neurovascular unit.
Chio JCT; Wang J; Badner A; Hong J; Surendran V; Fehlings MG
J Neuroinflammation; 2019 Jul; 16(1):141. PubMed ID: 31288834
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G (IgG) attenuates neuroinflammation and improves neurobehavioral recovery after cervical spinal cord injury.
Nguyen DH; Cho N; Satkunendrarajah K; Austin JW; Wang J; Fehlings MG
J Neuroinflammation; 2012 Sep; 9():224. PubMed ID: 22998664
[TBL] [Abstract][Full Text] [Related]
6. Attenuating Neurogenic Sympathetic Hyperreflexia Robustly Improves Antibacterial Immunity After Chronic Spinal Cord Injury.
Mironets E; Fischer R; Bracchi-Ricard V; Saltos TM; Truglio TS; O'Reilly ML; Swanson KA; Bethea JR; Tom VJ
J Neurosci; 2020 Jan; 40(2):478-492. PubMed ID: 31754014
[TBL] [Abstract][Full Text] [Related]
7. Chronic spinal cord injury attenuates influenza virus-specific antiviral immunity.
Bracchi-Ricard V; Zha J; Smith A; Lopez-Rodriguez DM; Bethea JR; Andreansky S
J Neuroinflammation; 2016 May; 13(1):125. PubMed ID: 27245318
[TBL] [Abstract][Full Text] [Related]
8. Self-assembling peptides optimize the post-traumatic milieu and synergistically enhance the effects of neural stem cell therapy after cervical spinal cord injury.
Zweckberger K; Ahuja CS; Liu Y; Wang J; Fehlings MG
Acta Biomater; 2016 Sep; 42():77-89. PubMed ID: 27296842
[TBL] [Abstract][Full Text] [Related]
9. Natural IgM antibodies that bind neoepitopes exposed as a result of spinal cord injury , drive secondary injury by activating complement.
Narang A; Qiao F; Atkinson C; Zhu H; Yang X; Kulik L; Holers VM; Tomlinson S
J Neuroinflammation; 2017 Jun; 14(1):120. PubMed ID: 28629465
[TBL] [Abstract][Full Text] [Related]
10. Level-Specific Differences in Systemic Expression of Pro- and Anti-Inflammatory Cytokines and Chemokines after Spinal Cord Injury.
Hong J; Chang A; Zavvarian MM; Wang J; Liu Y; Fehlings MG
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044384
[TBL] [Abstract][Full Text] [Related]
11. Altered Circulating Immune Cell Distribution in Traumatic Spinal Cord Injury Patients in Relation to Clinical Parameters.
Fraussen J; Beckers L; van Laake-Geelen CCM; Depreitere B; Deckers J; Cornips EMJ; Peuskens D; Somers V
Front Immunol; 2022; 13():873315. PubMed ID: 35837411
[TBL] [Abstract][Full Text] [Related]
12. Incomplete Spinal Cord Injury Reverses the Level-Dependence of Spinal Cord Injury Immune Deficiency Syndrome.
Hong J; Chang A; Liu Y; Wang J; Fehlings MG
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31374824
[TBL] [Abstract][Full Text] [Related]
13. Generating level-dependent models of cervical and thoracic spinal cord injury: Exploring the interplay of neuroanatomy, physiology, and function.
Wilcox JT; Satkunendrarajah K; Nasirzadeh Y; Laliberte AM; Lip A; Cadotte DW; Foltz WD; Fehlings MG
Neurobiol Dis; 2017 Sep; 105():194-212. PubMed ID: 28578003
[TBL] [Abstract][Full Text] [Related]
14. Implications of immunotherapy with high-dose glatiramer acetate in acute phase of spinal cord injury in rats.
Askarifirouzjaei H; Khajoueinejad L; Salek Farrokhi A; Tahoori MT; Fazeli M; Tiraihi T; Pourfathollah AA
Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):150-162. PubMed ID: 31038378
[No Abstract] [Full Text] [Related]
15. Cellular Inflammatory Response of the Spleen After Acute Spinal Cord Injury in Rat.
Wu F; Ding XY; Li XH; Gong MJ; An JQ; Lai JH; Huang SL
Inflammation; 2019 Oct; 42(5):1630-1640. PubMed ID: 31102125
[TBL] [Abstract][Full Text] [Related]
16. Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection.
Satkunendrarajah K; Nassiri F; Karadimas SK; Lip A; Yao G; Fehlings MG
Exp Neurol; 2016 Feb; 276():59-71. PubMed ID: 26394202
[TBL] [Abstract][Full Text] [Related]
17. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
Fleming JC; Bao F; Chen Y; Hamilton EF; Gonzalez-Lara LE; Foster PJ; Weaver LC
J Neurosurg Spine; 2009 Nov; 11(5):575-87. PubMed ID: 19929361
[TBL] [Abstract][Full Text] [Related]
18. Splenic involvement in umbilical cord matrix-derived mesenchymal stromal cell-mediated effects following traumatic spinal cord injury.
Badner A; Hacker J; Hong J; Mikhail M; Vawda R; Fehlings MG
J Neuroinflammation; 2018 Aug; 15(1):219. PubMed ID: 30075797
[TBL] [Abstract][Full Text] [Related]
19. Diffusion tensor imaging as a biomarker for assessing neuronal stem cell treatments affecting areas distal to the site of spinal cord injury.
Jirjis MB; Valdez C; Vedantam A; Schmit BD; Kurpad SN
J Neurosurg Spine; 2017 Feb; 26(2):243-251. PubMed ID: 27689421
[TBL] [Abstract][Full Text] [Related]
20. Alterations in immune cell phenotype and function after experimental spinal cord injury.
Popovich PG; Stuckman S; Gienapp IE; Whitacre CC
J Neurotrauma; 2001 Sep; 18(9):957-66. PubMed ID: 11565606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
